unknown
Stage
1
Investors
About
Hinge Bio develops a broadly applicable biologics platform to generate therapeutic candidates across rare disease, oncology, and immunology indications. The company is listed as preclinical and active on the investor's portfolio page.
Explore Hinge Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.